采纳股份收盘上涨3.28%，滚动市盈率85.13倍，总市值30.41亿元

Group 1 - The core viewpoint of the news is that Canan Technology Co., Ltd. has experienced a significant decline in its financial performance, with a notable drop in revenue and net profit in the latest quarterly report [1] - As of August 11, Canan's stock closed at 24.88 yuan, up 3.28%, with a rolling PE ratio of 85.13, marking a new low in 176 days [1] - The company's total market capitalization is 3.041 billion yuan, ranking 103rd in the medical device industry, which has an average PE ratio of 56.56 and a median of 39.76 [1][2] Group 2 - In terms of financial performance, Canan reported a revenue of 72.7093 million yuan for Q1 2025, a year-on-year decrease of 34.28%, and a net profit of 7.6802 million yuan, down 69.34% [1] - The gross profit margin for the company stands at 31.15% [1] - The company specializes in the research, production, and sales of injection and puncture instruments and laboratory consumables, and is recognized as a specialized and innovative small and medium-sized enterprise in Jiangsu Province [1]